A Study of Zanubrutinib in Patients With ITP

Clinical trial NCT05279872 · COMPLETED

Trial details

NCT number: NCT05279872
Sponsor: Peking University People's Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia Bruton Tyrosine Kinase

Start date: 2022-01-01
Primary completion: 2022-10-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.